CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE

美国国立卫生研究院（NIH），尤尼斯·肯尼迪·施莱佛国家儿童健康和人类发展研究所（NICHD），是进行基础、临床研究以开发新的避孕药具和评估现有避孕方法和生殖健康的牵头联邦机构。国家排雷中心内的人口研究中心的重要目标是通过合同和赠款开发新的避孕药具。在避孕和生殖健康方案内，避孕和生殖健康分支（CRHB）长期以来一直支持几个临床前避孕测试设施以及合成化学品和合成肽制剂设施。 为了进一步扩大其避孕开发能力，CRHB于1996年建立了NICHD避孕临床试验网络。目前的CCTN已经进行了I期、II期和III期临床试验。随着CCTN的重新竞争，临床研究中心将对各种新的或现有的女性避孕方法进行I期、II期、III期和IV期临床试验。

The National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is the lead Federal agency for the conduct of basic, clinical research to develop new contraceptives and to evaluate existing methods of contraception and reproductive health. The Center for Population Research (CPR), within NICHD, has the important goal of developing new contraceptives through the use of contracts and grants. Within CPR, the Contraception and Reproductive Health Branch (CRHB) has long supported several preclinical contraceptive testing facilities as well as facilities for synthetic chemical and synthetic peptide formulation. To further expand their contraceptive development capabilities, in 1996 CRHB established the NICHD Contraceptive Clinical Trials Network (CCTN). The current CCTN has conducted Phase I, II, and III clinical trials. With the recompetition of the CCTN, clinical sites will perform Phase I, II, III, and Phase IV clinical trials of a wide variety of new or existing female contraceptive methods.